Mytos, a London-based biotech startup, is tackling this bottleneck head-on with its fully automated, closed manufacturing platform...
First-in-human cases lay the foundation for the next frontier in robotic microsurgery...
The Elecsys Troponin T hs Gen 6 test offers enhanced analytical sensitivity, superior robustness, and unprecedented standardization demonstrating traceability to NIST reference materials...
The first facility, located within the Cell and Gene Therapy Catapult’s (CGT Catapult) Stevenage Manufacturing Innovation Centre, aims to achieve clinical readiness by September 2026...
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage...
A turnkey, radiation-free interventional platform designed to bring precision, safety, and real-time imaging to procedures in oncology, pediatrics, and structural heart interventions...
EkaScribe is trained to understand the Indian healthcare context and is optimized for real-world consultations...
The company is preparing for commercial rollout in Europe, where France has emerged as the single largest opportunity, given its high contraceptive usage yet limited permanent alternatives...
H2 Global Group, together with its subsidiary H2 Medical Technologies, has entered a decisive growth stage following strong recognition at LSI Europe 2025 in London...
This collaboration underscores the critical role of pairing automation with high-quality, standardized reagents in building scalable, reliable, and GMP-compliant workflows for next-generation therapies...
